USPTO Wants Antibody Patent Case Sent Back For Review
The U.S. Patent and Trademark Office says the Federal Circuit should terminate Xencor Inc.'s appeal of a Patent Trial and Appeal Board decision that backed an examiner's denial of an application...To view the full article, register now.
Already a subscriber? Click here to view full article